Wianny Florence, Vezoli Julien
Univ Lyon, Université Claude Bernard Lyon 1, Inserm, Stem Cell and Brain Research Institute U1208, 69500 Bron, France.
Ernst Strüngmann Institute (ESI) for Neuroscience in Cooperation with Max Planck Society, 60528 Frankfurt, Germany.
Primate Biol. 2017 Oct 11;4(2):185-213. doi: 10.5194/pb-4-185-2017. eCollection 2017.
In order to calibrate stem cell exploitation for cellular therapy in neurodegenerative diseases, fundamental and preclinical research in NHP (nonhuman primate) models is crucial. Indeed, it is consensually recognized that it is not possible to directly extrapolate results obtained in rodent models to human patients. A large diversity of neurological pathologies should benefit from cellular therapy based on neural differentiation of stem cells. In the context of this special issue of Primate Biology on NHP stem cells, we describe past and recent advances on cell replacement in the NHP model of Parkinson's disease (PD). From the different grafting procedures to the various cell types transplanted, we review here diverse approaches for cell-replacement therapy and their related therapeutic potential on behavior and function in the NHP model of PD.
为了校准干细胞在神经退行性疾病细胞治疗中的应用,在非人类灵长类动物(NHP)模型中进行基础和临床前研究至关重要。事实上,人们普遍认为,不可能将在啮齿动物模型中获得的结果直接外推到人类患者身上。多种神经病理学疾病应能从基于干细胞神经分化的细胞治疗中受益。在《灵长类生物学》关于NHP干细胞的这一特刊中,我们描述了帕金森病(PD)NHP模型中细胞替代的过去和近期进展。从不同的移植程序到移植的各种细胞类型,我们在此回顾了细胞替代疗法的多种方法及其在PD NHP模型中对行为和功能的相关治疗潜力。